Biologic for MS Linked to Reduced Vaccine Response Ocrelizumab treatment associated with decreased humoral response Jun 01, 2018
PPAR-Gamma Drug May Work in MS In phase II study, drug diminished inflammatory lesions & cortical atrophy May 30, 2017
McDonald Criteria for MS May Incorporate CSF Testing Revision committee finds OCB testing may be useful in specific cases May 25, 2017
Home-Based DVD May Motivate Seniors With MS to Exercise Patients reported improvements in physical fitness, self-confidence Jun 07, 2016
Lemtrada Offers Long-Term Stability in MS Patients Mean change in EDSS score was only +0.06 Jun 05, 2016
Lymphopenia Risk Factors to Watch With DMF Age, race, baseline lymphocytes, overweight, & vitamin D levels included Jun 03, 2016
Getting a Handle on Lymphopenia With Tecfidera Label-recommended interval for lymphocyte checks may be too long. Jun 02, 2015
Novel MS Drug Offers Good Functional Outcomes Daclizumab HYP beats interferon for patient-centered outcomes Jun 02, 2015
No Surprises with Tysabri-Tecfidera Switch Discontinuation rates for both agents were in line with those seen in clinical trials Jun 01, 2015
Ballroom Dance a Boon to MS Patients A small study finds ballroom dance -- waltz, salsa, foxtrot, and others -- may improve function in MS patients. May 29, 2015
